Endothelial progenitor cells give rise to pro-angiogenic smooth muscle-like progeny

Cardiovascular Research

Volumn 86, Issue 3, 2010, Pages 506-515

  Moonen, Jan Renier A J ^a   Krenning, Guido ^a   Brinker, Marja G L ^a   Koerts, Jasper A ^a   Van Luyn, Marja J A ^a   Harmsen, Martin C ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

EndMT; Endothelial progenitor cells; Plasticity; Smooth muscle cells; Transdifferentiation

Indexed keywords

ACTIVIN RECEPTOR LIKE KINASE 1; ALPHA SMOOTH MUSCLE ACTIN; ANGIOPOIETIN 1; ANGIOPOIETIN RECEPTOR; BIOLOGICAL MARKER; CALPONIN; CALVASCULIN; CD31 ANTIGEN; CD34 ANTIGEN; ENDOGLIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FIBROBLAST GROWTH FACTOR 2; INHIBITOR OF DIFFERENTIATION 3; MYOSIN; PLATELET DERIVED GROWTH FACTOR BB; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; SMAD PROTEIN; SMAD2 PROTEIN; SMOOTH MUSCLE MYOSIN HEAVY CHAIN 2; TELOMERASE REVERSE TRANSCRIPTASE; THROMBOMODULIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA1; TRANSGELIN; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN RECEPTOR 2; VON WILLEBRAND FACTOR;

ANGIOGENESIS; ARTICLE; CELL STIMULATION; CELL TRANSDIFFERENTIATION; CONTROLLED STUDY; CYTOSKELETON; ENDOTHELIAL COLONY FORMING CELL; ENDOTHELIAL TO MESENCHYMAL TRANSDIFFERENTIATION; ENDOTHELIUM CELL; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MESENCHYME CELL; MUSCLE CONTRACTILITY; NEWBORN; PARACRINE SIGNALING; PHENOTYPE; PRIORITY JOURNAL; PROGENY; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; STEM CELL; THROMBOGENESIS;

ANGIOPOIETIN-1; BIOLOGICAL MARKERS; CELL LINEAGE; CELL TRANSDIFFERENTIATION; CELLS, CULTURED; CYTOSKELETON; ENDOTHELIAL CELLS; FETAL BLOOD; FIBROBLAST GROWTH FACTOR 2; HUMANS; INHIBITOR OF DIFFERENTIATION PROTEINS; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NEOPLASM PROTEINS; NEOVASCULARIZATION, PHYSIOLOGIC; PARACRINE COMMUNICATION; PHENOTYPE; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SIGNAL TRANSDUCTION; SMAD2 PROTEIN; STEM CELLS; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA1; VASOCONSTRICTION;

EID: 77952330265     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvq012     Document Type: Article

References (48)

1. Lancrin C, Sroczynska P, Stephenson C, Allen T, Kouskoff V, Lacaud G. The haeman-gioblast generates haematopoietic cells through a haemogenic endothelium stage. Nature 2009;457:892-895.
2. Hellstrom M, Kalen M, Lindahl P, Abramsson A, Betsholtz C. Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development 1999;126:3047-3055.
3. Hirschi KK, Rohovsky SA, D'Amore PA. PDGF, TGF-beta, and heterotypic cell-cell interactions mediate endothelial cell-induced recruitment of 10T1/2 cells and their differentiation to a smooth muscle fate. J Cell Biol 1998;141:805-814.
4. Yamashita J, Itoh H, Hirashima M, Ogawa M, Nishikawa S, Yurugi T et al. Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors. Nature 2000; 408:92-96.
5. Ferreira LS, Gerecht S, Shieh HF, Watson N, Rupnick MA, Dallabrida SM et al. Vascular progenitor cells isolated from human embryonic stem cells give rise to endothelial and smooth muscle like cells and form vascular networks in vivo. Circ Res 2007;101:286-294.
6. Markwald RR, Fitzharris TP, Manasek FJ. Structural development of endocardial cushions. Am J Anat 1977;148:85-119.
7. Mercado-Pimentel ME, Hubbard AD, Runyan RB. Endoglin and Alk5 regulate epithelial-mesenchymal transformation during cardiac valve formation. Dev Biol 2007; 304:420-432.
8. DeRuiter MC, Poelmann RE, VanMunsteren JC, Mironov V, Markwald RR, Gittenberger-de Groot AC. Embryonic endothelial cells transdifferentiate into mesenchymal cells expressing smooth muscle actins in vivo and in vitro. Circ Res 1997;80:444-451.
9. Arciniegas E, Sutton AB, Allen TD, Schor AM. Transforming growth factor beta 1 promotes the differentiation of endothelial cells into smooth muscle-like cells in vitro. J Cell Sci 1992;103:521-529.
10. Frid MG, Kale VA, Stenmark KR. Mature vascular endothelium can give rise to smooth muscle cells via endothelial-mesenchymal transdifferentiation: in vitro analysis. Circ Res 2002;90:1189-1196.
11. Ishisaki A, Hayashi H, Li AJ, Imamura T. Human umbilical vein endothelium-derived cells retain potential to differentiate into smooth muscle-like cells. J Biol Chem 2003;278:1303-1309.
12. Krenning G, Moonen JR, van Luyn MJ, Harmsen MC. Vascular smooth muscle cells for use in vascular tissue engineering obtained by endothelial-to- mesenchymal transdif-ferentiation (EnMT) on collagen matrices. Biomaterials 2008;29:3703-3711.
13. Paranya G, Vineberg S, Dvorin E, Kaushal S, Roth SJ, Rabkin E et al. Aortic valve endo-thelial cells undergo transforming growth factor-beta-mediated and non-transforming growth factor-beta-mediated transdifferentiation in vitro. Am J Pathol 2001;159: 1335-1343.
14. Krenning G, Moonen JR, van Luyn MJ, Harmsen MC. Generating new blood flow: integrating developmental biology and tissue engineering. Trends Cardiovasc Med 2008;18: 314-324.
15. Zeisberg EM, Tarnavski O, Zeisberg M, Dorfman AL, McMullen JR, Gustafsson E et al. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat Med 2007; 13:952-961.
16. Kalka C, Masuda H, Takahashi T, Kalka-Moll WM, Silver M, Kearney M et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascu-larization. Proc Natl Acad Sci USA 2000;97:3422-3427.
17. Yoder MC, Mead LE, Prater D, Krier TR, Mroueh KN, Li F et al. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 2007;109:1801-1809.
18. Krenning G, van der Strate B, Schipper M, van Seijen XJGY, Fernandes B et al. CD34(\+) cells augment endothelial cell differentiation of CD14(\+) endothelial progenitor cells in vitro. J Cell Mol Med 2008;13:2521-2533.
19. Popa ER, van der Strate BW, Brouwer LA, Tadema H, Schipper M, Fernandes B et al. Dependence of neovascularization mechanisms on the molecular microenvironment. Tissue Eng 2007;13:2913-2921.
20. Krenning G, van Luyn MJ, Harmsen MC. Endothelial progenitor cell-based neovascu-larization: implications for therapy. Trends Mol Med 2009;15:180-189.
21. Hirschi KK, Ingram DA, Yoder MC. Assessing identity, phenotype, and fate of endo-thelial progenitor cells. Arterioscler Thromb Vasc Biol 2008;28:1584-1595.
22. Ingram DA, Mead LE, Tanaka H, Meade V, Fenoglio A, Mortell K et al. Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood 2004;104:2752-2760.
23. Moonen JR, de Leeuw K, van Seijen XJGY, Kallenberg CG, van Luyn MJ et al. Reduced number and impaired function of circulating progenitor cells in patients with systemic lupus erythematosus. Arthritis Res Ther 2007;9:R84.
24. Fukata Y, Amano M, Kaibuchi K. Rho-Rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of non-muscle cells. Trends Pharmacol Sci 2001;22: 32-39.
25. Goumans MJ, Valdimarsdottir G, Itoh S, Lebrin F, Larsson J, Mummery C et al. Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFbeta/ALK5 signaling. Mol Cell 2003;12:817-828.
26. Norton JD. ID helix-loop-helix proteins in cell growth, differentiation and tumorigen-esis. J Cell Sci 2000;113:3897-3905.
27. Ruzinova MB, Benezra R. Id proteins in development, cell cycle and cancer. Trends Cell Biol 2003;13:410-418.
28. Chen X, Zankl A, Niroomand F, Liu Z, Katus HA, Jahn L et al. Upregulation of ID protein by growth and differentiation factor 5 (GDF5) through a smad-dependent and MAPK-independent pathway in HUVSMC. J Mol Cell Cardiol 2006;41:26-33.
29. Iwasaki K, Hayashi K, Fujioka T, Sobue K. Rho/Rho-associated kinase signal regulates myogenic differentiation via myocardin-related transcription factor-A/Smad-dependent transcription of the Id3 gene. J Biol Chem 2008;283:21230-21241.
30. Saika S, Ikeda K, Yamanaka O, Flanders KC, Ohnishi Y, Nakajima Y et al. Adenoviral gene transfer of BMP-7, Id2, or Id3 suppresses injury-induced epithelial-to-mesenchymal transition of lens epithelium in mice. Am J Physiol Cell Physiol 2006;290: C282-C289.
31. Kowanetz M, Valcourt U, Bergstrom R, Heldin CH, Moustakas A. Id2 and Id3 define the potency of cell proliferation and differentiation responses to transforming growth factor beta and bone morphogenetic protein. Mol Cell Biol 2004;24: 4241-4254.
32. Arras M, Ito WD, Scholz D, Winkler B, Schaper J, Schaper W. Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb. J Clin Invest 1998;101: 40-50.
33. De Falco E, Porcelli D, Torella AR, Straino S, Iachininoto MG, Orlandi A et al. SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells. Blood 2004;104:3472-3482.
34. Zemani F, Silvestre JS, Fauvel-Lafeve F, Bruel A, Vilar J, Bieche I et al. Ex vivo priming of endothelial progenitor cells with SDF-1 before transplantation could increase their proangiogenic potential. Arterioscler Thromb Vasc Biol 2008;28:644-650.
35. Asahara T, Murohara T, Sullivan A, Silver M, van der ZR, Li T et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997;275:964-967.
36. Rafii S, Lyden D. Therapeutic stem and progenitor cell transplantation for organ vas-cularization and regeneration. Nat Med 2003;9:702-712.
37. Caplice NM, Bunch TJ, Stalboerger PG, Wang S, Simper D, Miller DV et al. Smooth muscle cells in human coronary atherosclerosis can originate from cells administered at marrow transplantation. Proc Natl Acad Sci USA 2003;100:4754-4759.
38. Liu C, Nath KA, Katusic ZS, Caplice NM. Smooth muscle progenitor cells in vascular disease. Trends Cardiovasc Med 2004;14:288-293.
39. Le Ricousse-Roussanne S, Barateau V, Contreres JO, Boval B, Kraus-Berthier L, Tobelem G. Ex vivo differentiated endothelial and smooth muscle cells from human cord blood progenitors home to the angiogenic tumor vasculature. Cardiovasc Res 2004;62:176-184.
40. Simper D, Stalboerger PG, Panetta CJ, Wang S, Caplice NM. Smooth muscle progenitor cells in human blood. Circulation 2002;106:1199-1204.
41. Brisset AC, Hao H, Camenzind E, Bacchetta M, Geinoz A, Sanchez JC et al. Intimal smooth muscle cells of porcine and human coronary artery express S100A4, a marker of the rhomboid phenotype in vitro. Circ Res 2007;100:1055-1062.
42. Nishishita T, Lin PC. Angiopoietin 1, PDGF-B, and TGF-beta gene regulation in endothelial cell and smooth muscle cell interaction. J Cell Biochem 2004;91: 584-593.
43. Pan D, Yang J, Lu F, Xu D, Zhou L, Shi A et al. Platelet-derived growth factor BB modulates PCNA protein synthesis partially through the transforming growth factor beta signalling pathway in vascular smooth muscle cells. Biochem Cell Biol 2007;85: 606-615.
44. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002;105: 1135-1143.
45. Volger OL, Fledderus JO, Kisters N, Fontijn RD, Moerland PD, Kuiper J et al. Distinctive expression of chemokines and transforming growth factor-beta signaling in human arterial endothelium during atherosclerosis. Am J Pathol 2007;171:326-337.
46. Frutkin AD, Otsuka G, Stempien-Otero A, Sesti C, Du L, Jaffe M et al. TGF-[beta]1 limits plaque growth, stabilizes plaque structure, and prevents aortic dilation in apo-lipoprotein E-null mice. Arterioscler Thromb Vasc Biol 2009;29:1251-1257.
47. Zoll J, Fontaine V, Gourdy P, Barateau V, Vilar J, Leroyer A et al. Role of human smooth muscle cell progenitors in atherosclerotic plaque development and composition. Cardiovasc Res 2008;77:471-480.
48. Foubert P, Matrone G, Souttou B, Lere-Dean C, Barateau V, Plouet J et al. Coadmi-nistration of endothelial and smooth muscle progenitor cells enhances the efficiency of proangiogenic cell-based therapy. Circ Res 2008;103:751-760.